Predicting survival beyond 5 years on continuous-flow left ventricular assist device: a landmark analysis from the STELLAR registry
Abstract Introduction Five-year survival after continuous-flow left ventricular assist device (LVAD) implantation has improved substantially, resulting in a growing population of ultra-long-term LVAD patients, defined as 5 years and longer survival on LVAD. Remarkably, determinants of mortality beyond the 5-year landma...